ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Verrica Pharmaceuticals (VRCA) Technical (Analysis) Reports Verrica Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Verrica Pharmaceuticals (VRCA)

Technical Analysis Report for NASDAQ stock VRCA Verrica Pharmaceuticals. Dated: 16 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock VRCA Verrica Pharmaceuticals then click here. or read Experts views on Verrica Pharmaceuticals or Forecast & share price targets of Verrica Pharmaceuticals

Verrica Pharmaceuticals Opened at 5.83 and Closed at: 6.00, which is 3.17% of previous session's close. It moved within a range of 5.67 and 6.13
The session was a Bullish session with an average volume of 43200, which is 28.01% of previous session's volumes.

  • There is some positive change in the short term trend, but its too soon to jump onto conclusions.

A Golden cross was found 2 days back on short term averages

A Golden cross was found 1 days back on long term averages

Support for tomorrow is 5.84 and resistance for tomorrow is 6.3
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 5.74, 5.47 resistance for tomorrow's hourly charts is 6.2, 6.39

10 Day SMA for Verrica Pharmaceuticals (VRCA) is 5.95 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Verrica Pharmaceuticals (VRCA) is 5.93 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Verrica Pharmaceuticals (VRCA) is 6.36 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 6.12 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Verrica Pharmaceuticals is 5.92 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Verrica Pharmaceuticals is at 5.93 and 200 DMA is at 5.92, while 50 DMA and 100 DMA are at 6.36 and 6.12 respectively

Verrica Pharmaceuticals (VRCA) moving average of 20 SMA is at 5.93 and 20 EMA is at 6.05

Verrica Pharmaceuticals (VRCA) moving average of 50 SMA is at 6.36 and 50 EMA is at 6.17

Verrica Pharmaceuticals (VRCA) moving average of 100 SMA is at 6.12 and 100 EMA is at 6.17

Verrica Pharmaceuticals (VRCA) moving average of 200 SMA is at 5.92 and 200 EMA is at 5.5

Xencor Inc has performed better than Verrica Pharmaceuticals in short term. You could have earned much better returns by investing in Xencor Inc, about 9.87% more returns!

Verrica Pharmaceuticals has performed better than Arbutus Biopharma in short term. Holding Verrica Pharmaceuticals could be a better choice for now!

Karyopharm Therapeutics has performed better than Verrica Pharmaceuticals in short term. You could have earned much better returns by investing in Karyopharm Therapeutics, about 14.49% more returns!

Verrica Pharmaceuticals has performed better than Atyr Pharma in short term. Holding Verrica Pharmaceuticals could be a better choice for now!

Verrica Pharmaceuticals has performed better than Arvinas Inc in short term. Holding Verrica Pharmaceuticals could be a better choice for now!

Verrica Pharmaceuticals has performed better than Seres Therapeutics in short term. Holding Verrica Pharmaceuticals could be a better choice for now!

Biolinerx has performed better than Verrica Pharmaceuticals in short term. You could have earned much better returns by investing in Biolinerx, about 6.48% more returns!

Neogenomics Inc has performed better than Verrica Pharmaceuticals in short term. You could have earned much better returns by investing in Neogenomics Inc, about 17.7% more returns!

Biomarin Pharmaceutical has performed better than Verrica Pharmaceuticals in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 3.37% more returns!

Caredx Inc has performed better than Verrica Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 5.97% more returns!

Verrica Pharmaceuticals has performed better than Cumberland Pharmaceuticals in short term. Holding Verrica Pharmaceuticals could be a better choice for now!

Verrica Pharmaceuticals has performed better than Proqr Therapeutics in short term. Holding Verrica Pharmaceuticals could be a better choice for now!

Surgery Partners has performed better than Verrica Pharmaceuticals in short term. You could have earned much better returns by investing in Surgery Partners, about 3.26% more returns!

Verrica Pharmaceuticals has performed better than Insmed Inc in short term. Holding Verrica Pharmaceuticals could be a better choice for now!

Verrica Pharmaceuticals Technical analysis of indicators

Price action analysis of Verrica Pharmaceuticals (VRCA) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Verrica Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Verrica Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Verrica Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a SELL signal for Verrica Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Verrica Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 5.95 and Verrica Pharmaceuticals VRCA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Verrica Pharmaceuticals VRCA stock. Volume based technical analysis of Verrica Pharmaceuticals VRCA stock is negative.

Verrica Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock VRCA Verrica Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And VRCA Experts View which covers a lot of information including buying and selling signals

VRCA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Verrica Pharmaceuticals or View Candle Stick Charts here

Chart Verrica Pharmaceuticals (VRCA)  Technical (Analysis) Reports Verrica Pharmaceuticals [

Videos related to: Verrica Pharmaceuticals (VRCA) Technical (Analysis) Reports Verrica Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Verrica Pharmaceuticals (VRCA)  Technical (Analysis) Reports Verrica Pharmaceuticals [

 

Back to top